Lentogest (Hydroxyprogesterone Caproate)

Hydroxyprogesterone caproate binds to progesterone receptors in the uterus, providing a progestogenic effect that lessens uterine contractility, modulates inflammatory pathways, and helps maintain cervical stability, thereby supporting the continuation of pregnancy.

The specific dose and dosing schedule of Lentogest are determined by the prescribing clinician based on the patient’s clinical condition and risk profile. The prescriber will set the appropriate regimen.

Lentogest is intended for use during pregnancy to lower preterm birth risk, but its safety in breastfeeding has not been established. Clinicians should evaluate the benefit‑risk balance for each individual.

To order Lentogest, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Lentogest’s active ingredient, hydroxyprogesterone caproate, is a long‑acting progestogen that offers a different mechanism from agents such as progesterone gel or vaginal suppositories. It provides systemic exposure via intramuscular injection, which can be advantageous for patients who prefer less frequent dosing.

Lentogest should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. The product should be handled in accordance with aseptic techniques to maintain sterility.

Lentogest is supplied as a sterile injectable solution that is administered by a healthcare professional via intramuscular injection, typically into the gluteal or deltoid muscle, following the dosing schedule prescribed by the clinician.

Serious risks, though rare, include allergic reactions such as anaphylaxis, thromboembolic events like deep‑vein thrombosis, and potential liver function abnormalities. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Lentogest should be avoided in individuals with known hypersensitivity to hydroxyprogesterone caproate or any formulation excipients, and it should be used with caution in patients with severe liver disease or those taking other progestogenic or estrogenic medications without medical supervision.